Yes95%
Vol$400.00
Markets6
Event Group
EventKALSHI

Single EventKALSHIFinancials
Medtronic cardiovascular organic growth in fiscal 2027
Part of: Medtronic cardiovascular organic growth in fiscal 2027cardiovascular organic revenue growth in 2027 If Medtronic plc reports Above X cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes. This market refers to the annual figure reported in Medtronic plc's full fiscal year or Q4 earnings release. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners. This market w
YesLeading Yes Probability
95%
|
VolTotal Volume
$400.00
|
Markets
6
Medtronic cardiovascular organic growth in fiscal 2027

Yes
95%
|
Vol
$400.00
|
Markets
6
Market Price Graph
6 markets tracked
Will Medtronic plc report Above 6% cardiovascular organic revenue growth in fiscal 2027?
kalshi
No data available
All Markets(6)
| Market | Price |
|---|---|
Will Medtronic plc report Above 6% cardiovascular organic revenue growth in fiscal 2027? | 95% |
Will Medtronic plc report Above 7% cardiovascular organic revenue growth in fiscal 2027? | 91% |
Will Medtronic plc report Above 8% cardiovascular organic revenue growth in fiscal 2027? | 81% |
Will Medtronic plc report Above 9% cardiovascular organic revenue growth in fiscal 2027? | 61% |
Will Medtronic plc report Above 10% cardiovascular organic revenue growth in fiscal 2027? | 43% |
Markets (6)
Sort
